Extended‐release naltrexone reduces opioid relapse in justice population

Six months of treatment with the extended‐release injectable formulation of naltrexone resulted in a lower rate of relapse to opioid use than conventional nonmedication treatment among adults in the criminal justice system, a study has found. The findings add to evidence that medication‐assisted treatment for opioid use disorders can be highly effective for an offender population that often lacks access to such treatment.

Source: The Brown University Psychopharmacology Update - June 22, 2016 Category: Psychiatry Tags: Special Populations Source Type: research